Peter Beitsch, MD
Surgical Oncology · Dallas, TXNPI 1336187731
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $57,255 of the $61,927 with a category attached, or 92.5%. Icad, Inc accounts for 75.6% of it on its own, with 32 other manufacturers making up the rest. Reporting peaked in 2020 at $26,590 and has fallen 97.8% since, to $587 in 2025. Among surgical oncology clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 102 payments — averaging $607.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Icad, Inc$47K
- Impedimed, Inc.$6K
- Merck$3K
- AstraZeneca$2K
- Endomagnetics Ltd$651
- Bard Peripheral Vascular, Inc.$600
- plus $3K from 27 others
What the payments were for
- Consulting fees$57,25592%
- Speaking & faculty fees$9001%
- Food & beverage$3,6606%
- Education$1120%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Icad, Inc | 17 | $46,789 |
| Impedimed, Inc. | 1 | $6,250 |
| Merck | 6 | $2,672 |
| AstraZeneca | 1 | $1,880 |
| Endomagnetics Ltd | 2 | $651 |
| Bard Peripheral Vascular, Inc. | 1 | $600 |
| Regeneron Healthcare Solutions, Inc. | 9 | $414 |
| Tactile Systems Technology Inc | 11 | $310 |
| QT Imaging, Inc. | 1 | $300 |
| Merit Medical Systems Inc | 3 | $296 |
| Myriad Genetic Laboratories, Inc. | 8 | $217 |
| Hologic Sales And Service, LLC | 3 | $181 |
| Novartis | 9 | $159 |
| Leica Microsystems Inc. | 3 | $148 |
| Axogen | 1 | $145 |
| Roche Diagnostics Corporation | 1 | $117 |
| E.r. Squibb & Sons, L.L.C. | 3 | $115 |
| Puma Biotechnology, Inc. | 1 | $108 |
| GE HealthCare | 4 | $102 |
| Integra Lifesciences Corporation | 2 | $56 |
| Covidien LP | 1 | $48 |
| Cashflow Solutions, LLC | 2 | $45 |
| Dilon Technologies, Inc. | 1 | $45 |
| Elucent Medical | 2 | $44 |
| Biom'up France SAS | 1 | $42 |
| Smith+Nephew | 1 | $37 |
| Acera Surgical, Inc. | 1 | $34 |
| Somavac Medical Solutions, Inc. | 1 | $34 |
| Davol Inc. | 1 | $25 |
| Vertex | 1 | $18 |
| Normatec Industries, LP | 1 | $17 |
| Sirius Medical Systems | 1 | $17 |
| Sanara Medtech Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Mammography-Powerlook AMP$26,250
- AXXENT SURFACE CONTROLLER$20,539
- LYNPARZA$1,880
- Magseed$794
- Magtrace$350
- QTScanner$300
- Savi SCOUT$264
- LIBTAYO$234
- Flexitouch Plus$142
- Entre Plus$142
- KEYTRUDA$122
- DIS Navify Software$117
- Nerlynx$108
How this compares
$61,927 in reported general payments places this provider in the 95th percentile of 191 surgical oncology providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Letrozole | 74 | $1,837 |
| Anastrozole | 44 | $605 |
| Tamoxifen Citrate | 19 | $560 |
| Tramadol Hcl | 86 | $280 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 33 | $175 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 21 | $121 |
Paid to pharmacies, not to this prescriber.
Other surgical oncology in Dallas
- Allison DipasqualeDallas$272K
- Adam YoppDallas$96K
- Patricio PolancoDallas$61K
- William McNamaraDallas$16K
- Glen BalchDallas$11K
- Michael ChotiDallas$6K
- Deborah FarrDallas$4K
- David KangDallas$4K
- Merrick RossHouston$216K
- John HardawayShenandoah$164K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.